Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    CIDP is added as a listed condition, and a Genetic and Rare Diseases Information Center resource link is included.
    Difference
    0.1%
    Check dated 2026-03-30T02:12:59.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    - Added Naples, Italy 80131 and removed Napoli, Italy 80131 from the locations list. - Publication section updated with the Lancet Neurology ADHERE study citation and DOI; Revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T22:43:46.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:48:27.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Publications section now includes the Lancet Neurology ADHERE publication citation. The previous citation entry was removed.
    Difference
    0.0%
    Check dated 2026-02-22T06:04:25.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears as a minor metadata update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T02:35:50.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Revision metadata updated: v3.4.1 added and v3.4.0 removed.
    Difference
    0.0%
    Check dated 2026-02-07T23:31:58.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.